The terms “confirmatory" and "conformance" batches are inconsistently used in the industry. Since process validation is essential for maintaining compliance and detecting variability, we must work toward harmonization of the terms to avoid confusion.
- Supporting The Next Generation Of ADCs
 - Are You Still Evaluating CMOs When You Really Need A CDMO?
 - Here's A Thought: What If Gene Editing Didn't Use Bacterial Enzymes?
 - Dual Membrane Preconditioning Can Improve Concentration, Cut HCPs
 - Analyzing CAR-T Surface Proteins With Immunoprecipitation Coupled With Mass Spectrometry
 - Program Manager Alignment And Integration: Best Practices When Working With A CDMO
 - New Guide Aims To Build Robust Framework For Digital Validation Tools
 
EDITOR'S DESK
- 
                
            On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
AI consultant Kat Kozyrytska advocates for ethical AI adoption and explains its potential to foster collaboration across the industry.
 
Takeda head of process development, Amy Shaw, explains what factors to consider when scaling up or scaling out cell therapy manufacturing.
DeciBio partner Carl Schoellhammer, Ph.D., speaks on the record with Bioprocess Online's chief editor Tyler Menichiello at the 2025 BioProcess International conference in Boston.
Nobel laureate, David Baltimore passed away at 87 years old, on September 6, 2025. He was widely regarded as a scientific visionary who at just 37, co-discovered reverse transcriptase, an enzyme that flipped molecular biology on its head by showing that genetic information could flow from RNA back to DNA, not just the other way around.
During a Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up," panelists discuss a way forward for the industry to unlock the true flexibility and promise of single-use technology.
GUEST COLUMNISTS
- 
                
            Here's A Thought: What If Gene Editing Didn't Use Bacterial Enzymes?
Citing the dismally few wins for CRISPR/Cas9 and other gene editing systems, one scientist proposes delivering zinc finger DNA-binding peptides using AAV6 vectors.
 - 
                
            Dual Membrane Preconditioning Can Improve Concentration, Cut HCPs
Research from Penn State, the FDA, and Takeda shows how combination filtration and purification steps improve output and reduce impurities.
 - 
                
            Analyzing CAR-T Surface Proteins With Immunoprecipitation Coupled With Mass Spectrometry
Among other benefits, the approach can help compare CAR constructs, evaluate the effects of manufacturing processes, and monitor changes in protein interactions.
 - 
                
            Program Manager Alignment And Integration: Best Practices When Working With A CDMO
This Q&A discusses best practices for integrating program managers into a sponsor company and how program managers help bridge the gaps between various stakeholders.
 - 
                
            New Guide Aims To Build Robust Framework For Digital Validation Tools
The ISPE's new guide addresses software for managing digital assets related to qualification, verification, validation, and compliance assurance.
 - 
                
            Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms
The company developed a novel approach to address the historic lack of stability testing for underserved parts of the world, near the equator.
 - 
                
            How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides
A class of enzymes previously believed to be specific and intolerant of change might actually have broad applicability.
 - 
                
            Takeda Reimagines Biopharma Quality For The Digital Age
Artificial intelligence, even in its current form, is especially good at synthesizing large data sets. Here's how one company makes the most of it.
 
BIOPROCESSING WHITE PAPERS
- 
                
            Designing A Disinfectant Study For Your Cleanroom
Disinfectant efficacy studies are crucial for safeguarding the sterility of your manufacturing facilities. Gain expert insights into the intricacies of these important studies and how to design one.
 
- 
            Producing MSC-Derived Cell Therapies From Isolation To Large-Scale Expansion8/4/2025
Explore the journey of producing MSC-derived cell therapies, from initial isolation and expansion to final product formulation and storage, and learn how to optimize each step.
 - 
            Optimizing Poloxamer 1881/13/2025
Poloxamer 188 stabilizes proteins in liquid formulations and protects cells from shear stress. Molecular weight and hydrophobicity variations influence its effectiveness in different biopharmaceutical applications.
 - 
            Optimizing Aliquoting For Robust Cell And Gene Therapy Processes6/3/2024
Explore the challenges of liquid handling in cell and gene therapy processes as well as innovative solutions to simplify aliquoting in modern bioprocesses.
 - 
            Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs10/6/2025
Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.
 - 
            Best Practices In Formulation And Lyophilization Development: Proteins, mAbs And ADCs10/16/2024
Discover how advancements in pharmaceutical freeze-drying are reshaping the process through better product understanding, precise process control, and innovations in equipment efficiency.
 
BIOPROCESSING APP NOTES & CASE STUDIES
- FDA Releases Draft Guidance To Accelerate Biosimilar Development
 - Supporting The Next Generation Of ADCs
 - AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing
 - On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
 - On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing
 - On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.
 - Single-Use Standardization Starts At Home
 
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles digs into the industry’s growing focus on knowledge management as an indispensable facet of biomanufacturing and pharmaceutical development, exploring how it plays into risk management, quality, vendor relationships, and supply chain resilience.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Faster Tech Transfers Through Seamless Digital Transformation
 - Developing Your Risk-Based Approach To Single-Use System Integrity
 - Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes
 - Strategies For Enhancing Bioprocessing Productivity
 - The Case For Optimized And Excipient GMP Cell Culture Solutions
 
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.03.25 -- Master Your Purification Workflow
 - 11.03.25 -- Simplify The Journey Of Advancing Your Therapies To Patients
 - 11.03.25 -- How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides
 - 10.31.25 -- STREAM Edition: Developing Antibodies To Block Neuroinflammation
 - 10.31.25 -- On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing